Trial Profile
A Multi-Center, Single Dose, Phase I, Dosimetry, Biodistribution, and Safety Trial of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2020
Price :
$35
*
At a glance
- Drugs Flubrobenguane-(18F) (Primary)
- Indications Heart failure
- Focus Adverse reactions; Diagnostic use
- 08 May 2014 New trial record